Compare ISTR & CUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ISTR | CUVL |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | Australia |
| Employees | N/A | 16 |
| Industry | Major Banks | Miscellaneous |
| Sector | Finance | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 415.1M | 374.2M |
| IPO Year | 2014 | N/A |
| Metric | ISTR | CUVL |
|---|---|---|
| Price | $31.09 | $6.34 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $31.50 | N/A |
| AVG Volume (30 Days) | ★ 84.2K | 13.8K |
| Earning Date | 04-20-2026 | N/A |
| Dividend Yield | ★ 1.59% | N/A |
| EPS Growth | ★ 4.41 | N/A |
| EPS | ★ 1.38 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $66.56 | N/A |
| Revenue Next Year | $5.18 | N/A |
| P/E Ratio | $22.24 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $21.43 | $5.95 |
| 52 Week High | $31.27 | $8.20 |
| Indicator | ISTR | CUVL |
|---|---|---|
| Relative Strength Index (RSI) | 57.00 | 42.75 |
| Support Level | $28.75 | $6.33 |
| Resistance Level | $31.27 | $6.82 |
| Average True Range (ATR) | 0.54 | 0.43 |
| MACD | -0.02 | -0.10 |
| Stochastic Oscillator | 70.00 | 18.89 |
Investar Holding Corp is a U.S.-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashier's checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.
Clinuvel distributes a single product, Scenesse, the only approved treatment for phototoxic reactions specifically associated with a rare genetic disease called erythropoietic protoporphyria. EPP causes extreme pain or burns from brief exposure to light, affecting a patient's quality of life. Scenesse is a patented dissolvable implant, comparable in size with a rice grain, injected underneath the skin roughly every three months for ongoing protection. The implant controls the release of a synthetic drug which promotes the production of more melanin, thereby reducing pain and increasing tolerance for light exposure. The majority of Clinuvel's earnings stem from Europe and the US.